Citation

Summerlin-Grady L, Austin PN, Gabaldon DA. J. Perianesth. Nurs. 2017; 32(5): 464-471.

Copyright

(Copyright © 2017, Elsevier Publishing)

DOI

10.1016/j.jopan.2016.01.005

PMID

28938982

Abstract

PURPOSE: Propofol is a short-acting medication with fast cognitive and psychomotor recovery. However, patients are usually instructed not to drive a motor vehicle for 24 hours after receiving propofol. The purpose of this article was to review the evidence examining when it is safe to drive after receiving propofol for sedation for diagnostic and surgical procedures.

DESIGN: This is a systematic review of the literature.

METHODS: A search of the literature was conducted using Google Scholar, PubMed, and the Cochrane Library for the time period 1990 to 2015.

FINDINGS: Two randomized controlled trials and two observational studies met the inclusion criteria. Using a simulator, investigators examined driving ability of subjects who received modest doses (about 100 mg) of propofol for endoscopic procedures and surveyed subjects who drove immediately after discharge. There were methodological concerns with the studies such as small sample sizes, modest doses of propofol, and three of the four studies were done in Japan by the same group of investigators limiting generalizability.

CONCLUSION: This limited research suggests that it may be safe for patients to drive sooner than 24 hours after receiving propofol. However, large multicenter trials using heterogenous samples using a range of propofol doses are needed to support an evidence-based revision to the current discharge guidelines for patients receiving propofol.

Copyright © 2016 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.

Language: en

Keywords

automobile; driving; procedures; propofol; sedation